Applied Therapeutics Company Insiders

APLT Stock  USD 0.57  0.07  14.00%   
Applied Therapeutics' insiders are aggressively selling. The analysis of the overall insider sentiment regarding Applied Therapeutics suggests that vertually all insiders are panicking. Applied Therapeutics employs about 37 people. The company is managed by 12 executives with a total tenure of roughly 87 years, averaging almost 7.0 years of service per executive, having 3.08 employees per reported executive.

Insider Sentiment 0

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2025-03-04Riccardo PerfettiDisposed 10366 @ 0.44View
2025-02-06Leslie D FuntleyderDisposed 22950 @ 0.61View
2024-08-14Shoshana ShendelmanDisposed 119591 @ 5.93View
2024-08-12Shoshana ShendelmanDisposed 300000 @ 5.98View
2024-06-06Shoshana ShendelmanDisposed 61795 @ 4.32View
2024-06-04Real Estate Equitie AlexandriaDisposed 150000 @ 4.21View
Monitoring Applied Therapeutics' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.

Applied Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.7601) % which means that it has lost $0.7601 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.7339) %, meaning that it created substantial loss on money invested by shareholders. Applied Therapeutics' management efficiency ratios could be used to measure how well Applied Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Applied Therapeutics' Return On Capital Employed is comparatively stable compared to the past year. Return On Equity is likely to gain to 8.43 in 2025, whereas Return On Tangible Assets are likely to drop (2.64) in 2025. At this time, Applied Therapeutics' Total Current Liabilities is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 1.4 M in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 56.5 M in 2025.
Common Stock Shares Outstanding is likely to gain to about 101.7 M in 2025, despite the fact that Net Loss is likely to grow to (90.3 M).

Applied Therapeutics Workforce Comparison

Applied Therapeutics is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 1,591. Applied Therapeutics holds roughly 37.0 in number of employees claiming about 2.33% of equities under Health Care industry.

Applied Therapeutics Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Applied Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Applied Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Applied Therapeutics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Applied Therapeutics Notable Stakeholders

An Applied Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Applied Therapeutics often face trade-offs trying to please all of them. Applied Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Applied Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About Applied Therapeutics Management Performance

The success or failure of an entity such as Applied Therapeutics often depends on how effective the management is. Applied Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Applied management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Applied management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(2.51)(2.64)
Return On Capital Employed 4.54  4.77 
Return On Assets(2.51)(2.64)
Return On Equity 8.03  8.43 
Please note, the imprecision that can be found in Applied Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Applied Therapeutics. Check Applied Therapeutics' Beneish M Score to see the likelihood of Applied Therapeutics' management manipulating its earnings.

Applied Therapeutics Workforce Analysis

Traditionally, organizations such as Applied Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Applied Therapeutics within its industry.

Applied Therapeutics Manpower Efficiency

Return on Applied Therapeutics Manpower

Revenue Per Employee270.1K
Revenue Per Executive832.8K
Net Loss Per Employee3.2M
Net Loss Per Executive10M

Additional Tools for Applied Stock Analysis

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.